Revvity | PKI - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agilent USD 281.97M 252K 2026-06
Align Technology USD 71.62M 1000 2026-06
Bio Techne USD 156.45M 703K 2026-03
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Bruker USD 152.35M 130K 2026-06
Celltrion KRW 229.65M 11.03M 2026-03
Charles River Laboratories USD 47.73M 439K 2026-06
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 199.2M 1.1M 2026-06
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Divis Laboratories Ltd INR 265.47M 0 2026-03
Edwards Lifesciences USD 577M 3.7M 2026-03
Illumina USD 151.3M 607K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Kangmei Pharma CNY 13.83B 0 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Laboratory Of America USD 80.9M 1.4M 2026-06
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
Mettler Toledo International USD 20.21M 40.9K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Organigram Holdings CAD 136.47M 1.34M 2026-03
Ovoca Bio EUR 29.49M 0 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Pharma Mar EUR 17.34M 24.24K 2026-06
Qiagen NV USD 206.5M 245K 2026-06
Quest Diagnostics USD 110M 1000K 2026-06
Quidel USD 68.1M 200K 2026-03
Repligen USD 56.43M 28K 2026-06
Revvity USD 111.63M 174K 2026-06
Sartorius EUR 69.05M 0 2026-06
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Tilray USD 116.52M 5.01M 2025-09
Waters USD 98.19M 20K 2026-06
Zealand Pharma A/S 70.66M 53K 2026-03
Zz Pientze Pharmaceu CNY 603.32M 0 2026-06